Cdc28 Antibodies

Santa Cruz Biotechnology delivers a wide array of Cdc28 monoclonal antibodies for research in cell cycle regulation and checkpoint control. Cdc28 Antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Cdc28, also known as cyclin-dependent kinase 1 (CDK1), plays a crucial role in the regulation of the cell cycle, particularly in the transition from G2 phase to mitosis. Its activity is tightly controlled by cyclins and various regulatory proteins, making it essential for proper cell division and maintaining genomic stability. Dysregulation of Cdc28 can lead to uncontrolled cell proliferation and is implicated in various cancers. Understanding Cdc28's function and regulation is vital for advancing cancer research and developing targeted therapies. Researchers can utilize Cdc28 monoclonal antibodies to investigate cell cycle dynamics and protein interactions. Exploring Cdc28's role in cellular processes helps reveal potential therapeutic targets for cancer treatment. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of cell cycle regulation and its impact on human health.